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Objectives. We sought to determine the basis for restenosis
within superficial femoral arteries (SFAs) and hemodialysis con-
duits treated with balloon-expandable stents.
Background. Use of stents within coronary and peripheral
vessels continues to increase exponentially. The mechanism of
restenosis within stents placed at various vascular sites is not well
understood. In particular, the implications of deploying a balloon-
expandable stent in a compressible site are not well understood.
Methods. After the serendipitous detection of stent deformation
during intravascular ultrasound (IVUS) examination of a re-
stenosed dialysis fistula, we evaluated a consecutive series of
patients with stents placed in compressible vascular sites, includ-
ing the SFA (six patients) and hemodialysis fistulae (five pa-
tients). Clinical, angiographic and IVUS examinations were per-
formed to evaluate mechanisms of restenosis.
Results. Stent compression was identified as the principal
cause of restenosis in all dialysis conduits and SFAs. Stent
deformity was not reliably identified by angiography; however,
IVUS identified compression of two forms: eccentric deformation,
implicating two-point compressive force, and complete circumfer-
ential encroachment of stent struts around the catheter, suggest-
ing multidirectional compressive force. Despite redilation, sec-
ondary restenosis resulting from recurrent compression recurred
in most sites.
Conclusions. Restenosis within balloon-expandable endovascu-
lar stents may occur as a result of stent compression, a phenom-
enon readily detected by IVUS, but often not by angiography.
These findings have significant implications for the use of balloon-
expandable stents within vascular sites subject to extrinsic com-
pression, such as hemodialysis conduits, the adductor canal
segment of the SFA and carotid arteries.
(J Am Coll Cardiol 1997;29:328–38)
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It is estimated that endovascular stents will be implanted in
more than 100,000 patients in the United States alone in 1996,
and this number is expected to double by 1997 (1). This rapid
growth is the result of studies that have demonstrated that
endovascular stents may optimize the results of percutaneous
revascularization (2,3). Stents have been shown to be particu-
larly effective in counteracting undesirable consequences of
balloon dilation—namely, elastic recoil, flow-limiting dissec-
tion and abrupt occlusion (4–8). The ability to scaffold the
disrupted vessel wall using a stent may both salvage a subop-
timal result after balloon dilation and preserve long term the
acute gain in lumen dimensions. Randomized trials have, in
fact, demonstrated that for coronary arteries the use of stents
may reduce restenosis (2,3). Reports of nonrandomized trials
suggest a similar benefit applies to the aorta and iliac arteries
(8–13). Not surprisingly, given these encouraging results,
attempts have been made to extend the use of stents to other
sites of the vascular tree in which percutaneous revasculariza-
tion is complicated by a high frequency of restenosis. These
include aortocoronary saphenous vein grafts (14), renal arter-
ies (15), femoral arteries (12,16–18) and dialysis conduits
(19–21). Stents are likewise being employed in clinical trials of
carotid artery balloon angioplasty (22–25). The incidence of
stent restenosis for these newer sites remains incompletely
defined. In most cases of restenosis, however, the mechanism
of restenosis has been inferred to result from intimal hyper-
plasia (12,14,18).
Failure of stents placed in the coronary or iliac arteries to
prevent restenosis appears to be the result of neointimal
proliferation within the stent (4,26–30). Little consideration
has been given to mechanical factors that might contribute to
late stent failure.
Between September 1992 and September 1995, we identi-
fied the presence of stent compression as the principal cause of
restenosis in a series of patients treated with balloon-
expandable stents for vascular obstruction involving two unre-
lated vascular sites, hemodialysis conduits and the adductor
canal segment of the superficial femoral artery (SFA). Al-
though unrelated anatomically, these two vascular segments
have in common the feature of being susceptible to external
compressive forces. This report describes the features of stent
compression diagnosed by intravascular ultrasound (IVUS),
fluoroscopy and angiography, and the potential implications of
these findings for the application of stents in vascular segments
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subject to unfavorable extrinsic or intrinsic, or both, mechan-
ical forces.
Methods
Stents in hemodialysis conduits. Patients. Between Sep-
tember 1992 and January 1994, five hemodialysis patients
undergoing revascularization at St. Elizabeth’s Medical Center
in Boston for failing dialysis access sites were treated with one
or more Palmaz stents (Johnson & Johnson Interventional
Systems). One patient was treated with stents at two separate
sites. In all cases, the stents were used on a “compassionate”
basis to salvage a suboptimal result after percutaneous trans-
luminal angioplasty (PTA) or directional atherectomy (De-
vices for Vascular Intervention). Each of the six stent sites was
followed up longitudinally to evaluate patency.
Initial stent deployment. Patients were treated initially with
Palmaz balloon-expandable peripheral arterial or biliary stents
(Johnson & Johnson Interventional Systems). Standard tech-
nique for stent deployment was used (10). Two of the five
dialysis patients were treated with long-term oral anticoagula-
tion after initial stent deployment. Balloon size for stent
deployment was selected to match the diameter, measured by
IVUS, of an adjacent vascular segment of normal caliber
(“reference site”). After initial deployment, stents were eval-
uated by IVUS for the presence of underexpansion, defined by
either 1) the presence of struts protruding freely into the
lumen (nonapposition with the vessel wall), or 2) persistent
narrowing at the lesion site relative to the adjacent reference
site. Underexpanded stents were redilated with a larger bal-
loon or higher inflation pressure.
Clinical follow-up and detection of restenosis. Dialysis pa-
tients were followed closely after initial stent deployment to
determine the efficacy of dialysis and relief of symptoms and
physical findings (e.g., arm edema). Dialysis efficacy was as-
sessed at monthly intervals by measuring the urea reduction
ratio and venous return pressures while on dialysis. If symp-
toms returned or dialysis efficacy deteriorated, then angio-
graphic and IVUS examinations were repeated.
Angiographic evaluation. Contrast angiography at the time
of follow-up examination was performed in anteroposterior
and oblique projections, attempting to identify irregular stent
geometry. Quantitative analysis was performed using previ-
ously validated, automated edge-detection software (31); per-
cent lumen diameter and cross-sectional area (CSA) narrowing
were calculated in comparison to the reference site. Qualita-
tively, stent sites were examined for nonuniform expansion
deformity and stent narrowing.
Intravascular ultrasound examination. This was performed
during initial stent deployment and with each subsequent
intervention. The IVUS instrument consisted of a 3.5F mono-
rail catheter (Sonicath, Boston Scientific) housing a single-
element, 20-MHz transducer, which was rotated at 1,800 rpm.
Images were viewed on an IVUS Sonos console (Hewlett
Packard) and transferred to standard VHS videotape for
off-line analysis. Minimal (minor) and maximal (major) lumen
diameters, as well as lumen CSA, were measured at each
lesion. Uniformity of stent expansion was determined at the
time of each IVUS examination. A “uniformity index,” defined
as the ratio of minor to major lumen diameter, was calculated
for each site. A uniformity index of 1.0 indicated symmetric
circumferential expansion of the stent into a circular geometric
configuration. Eccentric stent compression was arbitrarily de-
termined to be present if the uniformity index was #0.6.
Treatment for restenosis. Restenotic stent sites were redi-
lated and additional Palmaz stents or Wallstents (Schneider
USA) were then placed at the discretion of the intervention-
alist to buttress the original stent or to treat new areas of
stenosis, or both. Retreatment for second and third episodes of
restenosis was performed as indicated.
Stents in the SFA. Patients. Between July 1994 and March
1995, patients at St. Elizabeth’s Medical Center presenting
with claudication due to stenosis or occlusion of the SFA were
enrolled in the Femoral Artery Stenting Trial (FAST) under
an Investigational Device Exemption granted to Johnson &
Johnson Interventional Systems and approved by the Human
Institutional Review Board at St. Elizabeth’s Medical Center.
Patients were prospectively randomized to treatment with
either conventional balloon angioplasty or PTA with adjunc-
tive Palmaz stent deployment. Subsequently, patients were
followed at regular intervals with office visits and noninvasive
evaluation. Repeat angiographic and IVUS examinations to
evaluate patency of the stent sites were performed 6 months
after initial stent deployment. Of the seven patients random-
ized to treatment with stents who have undergone 6-month
follow-up angiographic and IVUS examinations, six were ob-
served to have stent compression; these six constitute the SFA
cohort for the current report.
Initial stent deployment in the SFA was carried out using
standard technique (10) using Johnson & Johnson Interven-
tional Systems Palmaz biliary stents, premounted on polyeth-
ylene balloons (Meditech). Balloon size was selected based on
dimensions of the reference site, as measured by IVUS and
angiography. If more than one stent was required to span the
lesion, then additional stents were deployed in tandem, over-
lapping adjacent stents by 1 to 3 mm. After initial deployment,
high pressure inflation (12 to 15 atm) was performed with a
noncompliant balloon. Subsequently, IVUS was used to con-
firm the presence of complete and symmetrical stent expansion
and adequate strut apposition. Underexpanded stent sites were
retreated until deployment was deemed to be satisfactory by
IVUS. All patients with SFA stents received anticoagulation to
Abbreviations and Acronyms
ABI 5 ankle-brachial index
CSA 5 cross-sectional area
FAST 5 Femoral Artery Stent Trial
IVUS 5 intravascular ultrasound
PTA 5 percutaneous transluminal angioplasty
SFA 5 superficial femoral artery
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an international normalized ratio of 2.0 to 2.5 for 3 months and
were treated with aspirin (325 mg/day) for the duration of the
follow-up period.
Clinical, angiographic and IVUS follow-up in patients with
SFA stents. Patients with SFA stents were followed with
clinical and noninvasive evaluation at 1, 3 and 6 months.
Patients were monitored for recurrence of claudication. Ankle-
brachial index (ABI) was measured at rest at 1, 3 and 6 months
after stent implantation. Exercise treadmill performance, time
to onset of claudication and ABI immediately after graded
exercise (32,33) were measured at 1 and 6 months after stent
implantation.
Patients underwent follow-up angiographic and IVUS ex-
aminations at 6 months after stent implantation. Two or more
oblique angiographic views were obtained to evaluate the
vascular lumen for patency and the stent geometry for evi-
dence of asymmetry. Automated quantitative angiographic
analysis was performed to assess the degree of lumen narrow-
ing.
Intravascular ultrasound examination was systematically
performed in SFA stent sites at the time of 6-month angio-
graphic evaluation. Lumen dimensions, percent diameter and
CSA narrowing and uniformity index were all measured. Strut
apposition and thickness of neointimal lining were assessed
qualitatively.
Retreatment of SFA stent sites. Restenotic sites were redi-
lated in symptomatic patients, after which angiography and
IVUS confirmed uniform reexpansion of stents and restoration
of lumen dimensions. Patients were monitored thereafter with
clinical evaluation.
Results
Dialysis conduits. Six vascular sites in five patients with
dialysis conduit stenosis or occlusion were treated with Palmaz
stents. All six stent sites developed repeated episodes of
restenosis, each associated with stent compression, despite the
employment of aggressive strategies to maintain patency (Fig.
1 and 2). These strategies included the use of progressively
larger balloons or a higher inflation pressure to maximize stent
expansion, placement of additional balloon-expandable
Palmaz or self-expanding Wallstents and the use of anticoag-
ulation. Table 1 summarizes the clinical course of these five
dialysis patients, including intervals between episodes of re-
stenosis and the percent angiographic narrowing observed at
each episode. At the time of first or second restenosis, five
additional Palmaz stents and two self-expanding Wallstents
were placed in subclavian vein sites.
Figure 1. Stent compression of tandem ce-
phalic vein stents causing restenosis in the
dialysis conduit. A, Angiogram in left anterior
oblique projection demonstrates high grade,
tubular stenosis of stented segment. B, Intra-
vascular ultrasound from area of stent compres-
sion indicating slit-like lumen narrowing. Stent
struts (s) are free in lumen and encroaching
on IVUS probe (*). C, Longitudinal, three-
dimensional reconstruction from serial IVUS
frames; stent struts (s) protrude into lumen, en-
croaching on IVUS catheter along entire length
of stented segment. D, Three-dimensional cast
of diffusely narrowed segment. E, Angiogram
after redilation of stented segment. Lumen di-
ameter is now enlarged to normal caliber.
(PTA 5 percutaneous transluminal angio-
plasty.) F, Tomographic IVUS frame of redi-
lated stent. Circular lumen (L) geometry has
been restored, and struts (s) reexpanded to
scaffold vessel wall. G, Longitudinal three-
dimensional reconstruction of redilated vessel
depicts enlargement of lumen and struts (s) effac-
ing vessel wall. H, Three-dimensional cast of
lumen restored to normal caliber. Cobblestoned
appearance conferred by struts is apparent.
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Intravascular ultrasound examination in dialysis conduits:
evidence of stent compression. Intravascular ultrasound mea-
surements of minor and major lumen dimension, CSA and
uniformity index for each lesion site are shown in Table 2. The
uniformity index immediately after initial stent deployment
was 0.89 6 0.25 (mean 6 SEM), indicating nearly concentric
geometry and uniform expansion. In contrast, at the initial
episode of restenosis, the ratio of minor to major lumen
dimension fell to 0.37 6 0.35, indicating eccentric stent com-
pression. Repeat PTA subsequently restored the circular ge-
ometry of the stents (uniformity index 0.90 6 0.27).
At the time of second restenosis, three of six sites were
unable to be imaged by IVUS, because of the inability to pass
the catheter through the occluded stent. However, the three
sites that were visualized again demonstrated stent compres-
sion (uniformity index 0.43 6 0.44). Repeat PTA, with or
without additional stent deployment, again restored a circular
configuration.
Eccentric stent deformation, with an associated decrease in
lumen CSA, recurred at all lesion sites, despite repeated
attempts to restore the desired circular configuration by more
aggressive PTA. Moreover, the placement of additional stents
within these sites, in an attempt to augment the radial strength
of the stents, failed to protect the stents from compression and
restenosis.
Fluoroscopic and angiographic imaging of dialysis con-
duits. Angiographic percent lumen diameter narrowing is
shown in Table 1. Before intervention percent diameter ste-
nosis was 75 6 5% (mean 6 SEM). After initial stent
deployment, lumen diameter was typically greater than that of
the reference site. At the first episode of restenosis, lumen
narrowing was reduced to 48 6 5%, but improved to 14 6 4%
after repeat dilation. At the second episode of restenosis,
lumen diameter narrowing was 87 6 4%; for the four vessels
that were again able to be redilated, residual narrowing was
4 6 5%.
Importantly, examination of the stents by fluoroscopy and
angiography was unreliable in identifying the presence or
absence of sent compression. Radiographic images in the
standard anteroposterior projection disclosed stent deformity
in only one case; however, even in this case, stent compression
Figure 2. Eccentric stent compression in left subclavian vein in dialysis
patient. A, Diagnostic angiogram of subclavian vein discloses resteno-
sis within distal one-third of stent. Arrows indicate outer border of
stent. Contrast column is separated from border of stent, implicating
neointimal proliferation as mechanism of restenosis. B, Intravascular
ultrasound (IVUS) frame from site of restenosis, depicting “slit-like”
or ovoid stent configuration of stent; ratio of minor to major dimension
is 0.24, consistent with stent compression. Stent struts (s) are bereft of
overlying neointimal thickening, indicating that compromise of the
lumen (L) is entirely due to stent compression. C, Angiogram after
repeat percutaneous transluminal coronary angioplasty (PTA) and
deployment of Wallstent depicts reexpansion of Palmaz stent. Contrast
column now approximates edges of stent (arrows). D, Intravascular
ultrasound frame from compressed site after redilation and Wallstent
deployment. Lumen (L) area is now enlarged and the configuration is
circular. Ratio of minor to major dimensions is 0.78. Cross-sectional
area increased from 17 mm2 before PTA to 75 mm2 after PTA.
(Asterisk indicates IVUS catheter.)
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was underestimated fluoroscopically, compared with the cor-
responding IVUS images. In certain instances, oblique views
disclosed stent asymmetry, suggesting possible stent compres-
sion. In most cases, however, particularly in subclavian vein
sites (Fig. 2), even oblique fluoroscopic views failed to show
stent deformation.
Superficial femoral artery sites. Table 3 summarizes the
clinical course, results of noninvasive evaluation and percent
angiographic stenosis before and after treatment and at 6
months follow-up for the six patients in whom a stent was
delivered to the SFA. In all patients lumen caliber post-stent
deployment (mean 2.86 0.9 stents/patient) was greater than or
equal to that of the reference vessel. Symptoms of claudication
(34), rest ABI and postexercise ABI improved after initial
treatment.
At 6-month angiographic and IVUS follow-up examina-
tions, restenosis at one or more stent sites was documented in
all six patients. Patient symptoms, rest ABI or postexercise
ABI, or all of these, were also consistent with restenosis.
Intravascular ultrasound examination of SFA stent sites.
Table 4 summarizes the IVUS findings for SFA stents. Percent
lumen CSA stenosis was improved from 84 6 3% before PTA
to 22 6 5% after stent deployment, but returned to 72 6 4%
at the 6-month IVUS examination. In contrast to uniform stent
expansion observed after initial deployment, IVUS examina-
tion at 6 months demonstrated compression of one or more
stents in each of the six patients (Fig. 3). Compression was
eccentric (uniformity index #0.6) in patients 2, 3, 5 and 6, and
concentric in patients 1 and 4. All six sites of SFA stent
compression were located within the adductor canal.
Five of the six patients were treated successfully with repeat
PTA. No new stents were deployed. Of note, the stents in
patients 1 and 5 reexpanded in an eccentric fashion, leaving an
ovoid lumen configuration and raising the possibility of a
persistent compressive force surrounding the SFA at these
sites.
Radiographic imaging of SFA stent sites: evidence of
compression. The results of quantitative angiographic analysis
for SFA stent compression are shown in Table 3. During initial
treatment and stent deployment, percent diameter stenosis,
using the anteroposterior view, was reduced from 67 6 3% to
25 6 3% at lesion sites. The identical sites at 6-month
follow-up angiography were narrowed angiographically by
71 6 5%.
Conventional anteroposterior radiographic imaging of SFA
stent sites consistently failed to reveal the presence of stent
deformity or compression (Fig. 3). In selected instances,
extremely angulated, in particular, lateral, views disclosed
eccentric stent deformation.
Discussion
The cases presented in this report illustrate a specific
mechanism—namely, stent compression—as the principal
cause for restenosis of stents deployed in dialysis conduits and
the SFA. The possibility that stents deployed at certain sitesTa
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might be liable to compression was a concern from the early
days of stent development. In designing his balloon-
expandable stent, Palmaz considered the possibility that the
circumferential elasticity, or “hoop stress,” of a given vessel
may produce enough force to overcome the radial strength of
the stent opposing it, resulting in inward collapse of the stent
struts (35). Hoop stress may vary, depending on vessel diam-
eter, wall thickness, type of vessel (muscular versus elastic),
plaque thickness, plaque content, degree of calcification and
characteristics of surrounding periadventitial tissues.
Isolated instances of stent compression have been reported
previously (36,37). Intrinsic elastic recoil has also been consid-
ered to be a factor potentially contributing to stent restenosis
(14,38,39). Bonner et al. (40) and Kimura et al. (30), in serial
angiographic studies after stent deployment, observed recoil of
;15% within the first week after the procedure. Painter et al.
(41), however, observed no recoil in stented coronary arteries
studied by IVUS and suggested that previous reports of lumen
loss attributed to stent recoil may actually have been due to
stent underexpansion, a feature not detected until IVUS
imaging was performed.
Despite early concerns during stent development about the
possibility of compression, and notwithstanding isolated case
reports, extrinsic compression has not been perceived to be a
predominant cause of stent failure or restenosis. Instead, most
reports have focused on the contribution of neointimal prolif-
eration within the stents (4,26–29).
Stent compression in dialysis conduits. Endovascular
stents have been used in an attempt to enhance the long-term
patency of dialysis conduits (19,36,42,43). Reports regarding
the use of balloon-expandable (Palmaz) stents in this setting
indicate a high rate of restenosis, but few reports have ad-
dressed the responsible mechanism. Elson et al. (36) alluded to
the possibility of stent compromise due to placement in
compressible sites. In one of their patients, a stent deployed in
the right subclavian vein would not expand fully during initial
placement, presumably owing to “extrinsic compression at
[the] first costo-clavicular junction.” A second patient devel-
oped occlusion of a stent placed in the common iliac vein
Figure 3. Angiographic, fluoroscopic and corresponding intravascular
ultrasound (IVUS) images obtained from the SFA in Patient 1 at
6-month (6 Mo) follow-up. Angiograms demonstrate several areas of
focal lumen narrowing within the stents (I–IV). A, Intravascular
ultrasound image from a stenotic site at the distal end of the most
proximal stent (I) demonstrates full expansion of stent struts (s) and
moderate restenosis within the struts due to neointimal hyperplasia
(neoint.). The circular configuration of the stent is preserved. (Asterisk
[*] indicates IVUS catheter.) B, Intravascular ultrasound image ob-
tained from the central portion of stent II demonstrates eccentric
deformation of the stent. The ratio of minor to major dimension
(3.6/6.1 5 0.59) confirms an eccentric configuration. C, Intravascular
ultrasound frame obtained from overlap region between stents II and
III. Struts (s) from overlapping stents abut the IVUS catheter, nearly
obliterating the lumen. D, Severe stent compression seen by IVUS in
the area of overlap between stents III and IV. Struts (s) from the inner
stent nearly abut the IVUS probe. Struts from the outer stent (O.S.)
are separated from the inner struts. It appears that compression
predominantly involves the inner stent, which is telescoped inside the
outer stent. E, Intravascular ultrasound image from the distal aspect of
the most distal stent (IV) demonstrates moderate restenosis from
concentric neointimal growth. The circular configuration of the stent
struts (s) indicates preservation of stent geometry and absence of
compression at this level. Note that after initial PTA, stents at
now-compressed sites (B, C, D and F) were equally as well expanded
as this. F, Intravascular ultrasound frame from the same site as D, with
measurements of lumen diameter and CSA. Fluoroscopy (FLUORO)
panel at right shows the location of the stents and areas of overlap. In
the anteroposterior (AP) view, mild compression is evident in the
overlap zone between stents II and III, possibly related to heavy calcific
deposits (Ca) bordering the stents on the right. At the site of most
severe compression (between stents III and IV, arrow), no obvious
stent deformity is seen on anteroposterior fluoroscopy.
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within two weeks, due to “two-point compressive forces”; the
computed tomographic scan depicted an ovoid stent configu-
ration similar to that seen by IVUS in our patients.
Two sites of stent compression in the present series of
patients were located in the proximal upper extremity, where
the brachial and cephalic veins have little surrounding tissue
(Fig. 1). It is likely that the stents within these vessels were
deformed by application of external compressive force on the
upper arm. Among the four patients with subclavian vein
stents, compression likely occurred between the first rib and
the clavicle at the costoclavicular junction (Fig. 2). Notably,
stent compression has not been identified as a significant
problem in coronary, renal or aortoiliac vessels. These vessels
may be relatively “protected” from extrinsic compression by
their location and surrounding support structures.
Stent compression in the SFA. Primary patency rates after
conventional PTA for stenotic or occlusive SFA disease are at
best as high as 40% to 70% at 3 to 5 years (44,45). Several
investigators have demonstrated the feasibility of placing stents
in the SFA, in hopes of improving long-term patency (12,16–
18). Henry et al. (12) reported a stent thrombosis rate of 22%
and a 6-month restenosis rate of 18.5% for 27 Palmaz stents
placed in the adductor canal segment of the SFA. All six of our
patients with SFA stent compression had the stent deployed
within the adductor canal. Therefore, much as the SFA
demonstrates a predilection to develop both primary disease
and restenosis after conventional PTA within the adductor
canal (46), it appears that this poor prognosis extends to
stenting in that same location. Presumably, stent failure at this
site is a consequence of extrinsic compression from the heavy
musculature and fibrous aponeurosis through which the SFA
traverses.
Detection of stent compression: radiographic versus IVUS
imaging. In each of our patients, IVUS provided the decisive
diagnosis of stent compression. Intravascular ultrasound imag-
ing after initial stent deployment confirmed the presence of
complete apposition of the struts against the endolumen
surface and circular lumen/stent geometry, with the initial
uniformity index close to unity for both dialysis conduits
(0.89 6 0.25) and SFA sites (0.91 6 0.28). Despite this,
restenosis or reocclusion occurred at least once in all SFA sites
and repeatedly in all dialysis patients. Although contrast
angiography readily identified the recurrence of lumen narrow-
ing, IVUS proved to be instrumental in identifying stent
compression as the mechanism of restenosis. Findings on
IVUS implicating this mechanism included an ovoid or “slit-
like” configuration of the stent and lumen (uniformity index
#0.6) and, in several instances, the presence of struts protrud-
ing into the lumen, abutting the IVUS catheter. These findings
were not immediately apparent from fluoroscopic and angio-
graphic examinations. In fact, in several instances, angiography
inaccurately implicated the presence of “conventional” resten-
osis because of intimal thickening. In these same instances,
IVUS depicted struts compressed around the catheter, with a
relative paucity of neointimal growth interior to the struts.
When stent deformation was demonstrated fluoroscopically, it
was only after steep angulated views were obtained to confirm
the results of the IVUS examination. The decisive detection of
stent compression by IVUS in the face of equivocal radio-
graphic findings thus underscores the utility of this imaging
technique to elucidate mechanisms of restenosis in vivo.
Implications of the current study. Stents are effective in
reducing restenosis, in part because they maximize the initial
gain in lumen CSA (26). In contrast, when placed in a vascular
segment subject to compressible forces, a stent may actually act
as a catalyst for further lumen compromise, on a mechanical,
rather than proliferative, basis. Indeed, as demonstrated in the
present series, restenosis may occur in the absence of any
obvious neointimal hyperplasia. The phenomenon of stent
compression seen in these patients thus illustrates an extreme
form of vascular remodeling (47). Experience in this series
suggests that the use of balloon-expandable prostheses in
vessel sites subject to extrinsic compression or extreme flexion
is undesirable. The clinical trial, FAST, in which all SFA stent
patients described herein were enrolled, has, in fact, been
prematurely terminated because of concerns of the manufac-
turer and investigators regarding SFA stent compression.
Similar concern may extend to other sites, such as the carotid
artery (22–25,48), where the consequences of stent compres-
sion are potentially devastating. Whether restenosis due to
stent compression may be eliminated by the use of self-
expanding stents or novel stent designs that incorporate more
resistance to compression remains to be determined.
We gratefully acknowledge the expert administrative assistance of Susan Pan-
zica.
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